ORAL VACCINES MARKET ANALYSIS
Global Oral Vaccines Market Drivers
Rising incidences of infections such as cholera, tuberculosis, and others are expected to propel growth of the oral vaccine market over the forecast period. For instance, according to the World Health Organization (WHO), 2019, around 1.3 million to 4.0 million cases of cholera and approximately 10 million cases of tuberculosis were reported globally in the year 2018.
Moreover, increasing government support towards new product approvals are expected to drive the oral vaccines market growth. For instance, in October 2018, Sanofi Pasteur received the prequalification status from the World Health Organization (WHO) for its inactivated Polio Vaccine (IPV), ShanIPV. The prequalification program ensures that the vaccines are safe and effective for the immunization programs. The prequalification status qualifies the vaccine ShanIPV for purchase by the agencies of the United Nations for various immunization programs.
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize NowWant to Buy a Report but have a Limited Budget?
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail
Request Discount
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients